These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 31227287)

  • 1. Metformin decreases bone turnover markers in polycystic ovary syndrome: a post hoc study.
    Lingaiah S; Morin-Papunen L; Risteli J; Tapanainen JS
    Fertil Steril; 2019 Aug; 112(2):362-370. PubMed ID: 31227287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reference intervals for serum concentrations of three bone turnover markers for men and women.
    Michelsen J; Wallaschofski H; Friedrich N; Spielhagen C; Rettig R; Ittermann T; Nauck M; Hannemann A
    Bone; 2013 Dec; 57(2):399-404. PubMed ID: 24076251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone markers in polycystic ovary syndrome: A multicentre study.
    Lingaiah S; Morin-Papunen L; Piltonen T; Puurunen J; Sundström-Poromaa I; Stener-Victorin E; Bloigu R; Risteli J; Tapanainen JS
    Clin Endocrinol (Oxf); 2017 Dec; 87(6):673-679. PubMed ID: 28845895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of denosumab on bone turnover markers in postmenopausal osteoporosis.
    Eastell R; Christiansen C; Grauer A; Kutilek S; Libanati C; McClung MR; Reid IR; Resch H; Siris E; Uebelhart D; Wang A; Weryha G; Cummings SR
    J Bone Miner Res; 2011 Mar; 26(3):530-7. PubMed ID: 20839290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin decreases serum 8-hydroxy-2'-deoxyguanosine levels in polycystic ovary syndrome.
    Sova H; Puistola U; Morin-Papunen L; Karihtala P
    Fertil Steril; 2013 Feb; 99(2):593-8. PubMed ID: 23122829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of bone turnover markers to the variation in bone mineral density: a study in Vietnamese men and women.
    Nguyen LT; Nguyen UDT; Nguyen TDT; Ho-Pham LT; Nguyen TV
    Osteoporos Int; 2018 Dec; 29(12):2739-2744. PubMed ID: 30196375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone Turnover Markers Are Not Associated With Hip Fracture Risk: A Case-Control Study in the Women's Health Initiative.
    Crandall CJ; Vasan S; LaCroix A; LeBoff MS; Cauley JA; Robbins JA; Jackson RD; Bauer DC
    J Bone Miner Res; 2018 Jul; 33(7):1199-1208. PubMed ID: 29923225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chinese bone turnover marker study: reference ranges for C-terminal telopeptide of type I collagen and procollagen I N-terminal peptide by age and gender.
    Li M; Li Y; Deng W; Zhang Z; Deng Z; Hu Y; Xia W; Xu L
    PLoS One; 2014; 9(8):e103841. PubMed ID: 25117452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trunk and Lower Extremity Movement Patterns, Stress Fracture Risk Factors, and Biomarkers of Bone Turnover in Military Trainees.
    Mauntel TC; Marshall SW; Hackney AC; Pietrosimone BG; Cameron KL; Peck KY; Trump JR; Padua DA
    J Athl Train; 2020 Jul; 55(7):724-732. PubMed ID: 32702112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Metformin vs. Placebo in Combination with Insulin Analogues on Bone Markers P1NP and CTX in Patients with Type 2 Diabetes Mellitus.
    Nordklint AK; Almdal TP; Vestergaard P; Lundby-Christensen L; Jørgensen NR; Boesgaard TW; Breum L; Gade-Rasmussen B; Sneppen SB; Gluud C; Hemmingsen B; Krarup T; Madsbad S; Mathiesen ER; Perrild H; Tarnow L; Thorsteinsson B; Vestergaard H; Lund SS; Eiken P
    Calcif Tissue Int; 2020 Aug; 107(2):160-169. PubMed ID: 32468187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of metformin, rosiglitazone and insulin on bone metabolism in patients with type 2 diabetes.
    Stage TB; Christensen MH; Jørgensen NR; Beck-Nielsen H; Brøsen K; Gram J; Frost M
    Bone; 2018 Jul; 112():35-41. PubMed ID: 29654849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone turnover alterations across the menopausal transition in south-eastern Chinese women [corrected].
    Ma L; Song Y; Li C; Wang E; Zheng D; Qu F; Zhou J
    Climacteric; 2016 Aug; 19(4):400-5. PubMed ID: 27147201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability.
    Szulc P; Naylor K; Hoyle NR; Eastell R; Leary ET;
    Osteoporos Int; 2017 Sep; 28(9):2541-2556. PubMed ID: 28631236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.
    Pollmann D; Siepmann S; Geppert R; Wernecke KD; Possinger K; Lüftner D
    Anticancer Res; 2007; 27(4A):1853-62. PubMed ID: 17649784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentrations of formation (PINP) and resorption (Ctx) bone turnover markers in rheumatoid arthritis.
    Wisłowska M; Jakubicz D; Stepień K; Cicha M
    Rheumatol Int; 2009 Oct; 29(12):1403-9. PubMed ID: 19219607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline bone turnover marker levels can predict change in bone mineral density during antiresorptive treatment in osteoporotic patients: the Copenhagen bone turnover marker study.
    Bønløkke SE; Rand MS; Haddock B; Arup S; Smith CD; Jensen JEB; Schwarz P; Hovind P; Oturai PS; Jensen LT; Møller S; Eiken P; Rubin KH; Hitz MF; Abrahamsen B; Jørgensen NR
    Osteoporos Int; 2022 Oct; 33(10):2155-2164. PubMed ID: 35729342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective Serotonin Reuptake Inhibitors (SSRIs) and Markers of Bone Turnover in Men.
    Williams LJ; Berk M; Hodge JM; Kotowicz MA; Stuart AL; Chandrasekaran V; Cleminson J; Pasco JA
    Calcif Tissue Int; 2018 Aug; 103(2):125-130. PubMed ID: 29441424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlations between biochemical markers of bone turnover and bone density responses in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate.
    Burshell AL; Möricke R; Correa-Rotter R; Chen P; Warner MR; Dalsky GP; Taylor KA; Krege JH
    Bone; 2010 Apr; 46(4):935-9. PubMed ID: 20060081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reference intervals for bone turnover markers in Spanish premenopausal women.
    Guañabens N; Filella X; Monegal A; Gómez-Vaquero C; Bonet M; Buquet D; Casado E; Cerdá D; Erra A; Martinez S; Montalá N; Pitarch C; Kanterewicz E; Sala M; Surís X; Torres F;
    Clin Chem Lab Med; 2016 Feb; 54(2):293-303. PubMed ID: 26088062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of age-related chronic immobility on markers of bone turnover.
    Chen JS; Cameron ID; Cumming RG; Lord SR; March LM; Sambrook PN; Simpson JM; Seibel MJ
    J Bone Miner Res; 2006 Feb; 21(2):324-31. PubMed ID: 16418789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.